Sign in

Lost your password?
(close)

Brexit

Pfizer’s Nordkamp Takes ABPI Presidency

Erik Nordkamp, managing director of Pfizer UK, has been confirmed as the new president of the Association of the British Pharmaceutical Industry (ABPI). With UK life sciences still uncertain as…

UK Life Sciences Firms Struggle in Post-Brexit War for EU Talent

UK pharmaceutical and biotech companies are already finding it increasingly difficult to attract talent from…

Brexit uncertainty forces AstraZeneca to freeze investment in the UK

Yesterday, pharma giant AstraZeneca announced that they have halted investment in the UK due to lack of clarity on…

Brexit: A Window of Opportunity for France’s Drug Regulator?

As the UK prepares to leave the European Union in March 2019, stakeholders across the European life sciences…

Latest Report

In Conversation

Interview: Haseeb Ahmad – Country President, Novartis UK

Only 14 months in position, UK country president at Novartis, Haseeb Ahmad, shares insights into the company’s new strategy. He further analyses how Brexit can be a catalysing force for the UK to lead in life sciences and explains why the country has potential as a test bed for medicine launches.     Much has changed at Novartis within the…

Geoffrey Guy, Chairman, GW Pharma

Chris Fox – General Manager, Amgen UK & Ireland

Brexit Facts & Figures Snapshot

There is much debate surrounding the potential impact on the UK’s life sciences industry of the…

Related Report

Brexit and Irish Pharma

The UK’s decision to leave the EU in Summer 2016 sent shockwaves throughout Europe and left neighbouring…

NHS England’s Long-Term Plan to be Funded by £20.5 Billion

Today NHS England have released their long-term plan to ensure the future of the NHS and the continued care of UK…

Roche boss: Brexit will make the UK less competitive

Last week, Roche Boss Severin Schwan expressed concern that Brexit could further slow the UK drug approval process.…

Brexit: A Serious Threat to Patients

As the UK extracts itself from the European Union, key figures from the country’s life sciences sector are…

The European Medicines Verification System Launches to Tackle Fake Drugs

The 9th February 2019 marked the launch of the European Medicines Verification System (EMVS) which will use…

Brexit: Much ado about nothing?

Brexit, Brexit, Brexit. It’s all anyone can talk about and yet nobody can tell you with certainty what to expect.…

Brexit Bites: EMA cuts off Britain

The European Medicines Agency has cut Britain out of its contracts 7 months ahead of Brexit. “You might have been…

We use cookies to ensure that we give you the best experience on our site. For more info click here